EU Qualified Person

Recent Articles

RELATED ARTICLES

  1. The Chinese drug developer put a rocket booster under its share price after enlisting a Japanese rival as a new equity partner and unveiling plans for a U.S. listing.
    Ascentage Pharma soars on deal with cancer drug competitor
    6855.HK
  2. Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
    1952.HK
  3. Akeso marks profit milestone with swift rights issue
    9926.HK
  4. CHINA BULLETIN: Manufacturing Déjà Vu
  5. BeiGene still bleeding red ink despite blockbuster drug
    BGNE.US 6160.HK 688235.SHG
  6. Facing revenue crisis, Ascletis Pharma tries to bulk up with obesity drugs
    1672.HK
  7. Everest reaches new heights on growing drug sales
    1952.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva